AL Lambda Amyloidosis Activates Acute Liver Failure in the Absence of Plasma Cell Dyscrasia

Dig Dis Sci. 2022 Jan;67(1):67-70. doi: 10.1007/s10620-021-07253-2. Epub 2021 Oct 15.

Abstract

A patient with systemic amyloidosis developed portal hypertension, acute liver failure and multiorgan dysfunction. Extensive testing was unrevealing for paraproteinemia, plasma cell dyscrasia, infectious, or inflammatory conditions. He was transferred to our institution for orthotopic liver transplant evaluation but was ultimately declined given clinical instability and dysautonomia. Post-mortem evaluation revealed extensive amyloid deposition in multiple organs determined to be AL-lambda amyloidosis.

Keywords: Acute liver failure; Amyloid; Portal hypertension.

Publication types

  • Case Reports

MeSH terms

  • Amyloidosis, Familial* / complications
  • Amyloidosis, Familial* / diagnosis
  • Amyloidosis, Familial* / physiopathology
  • Ascites* / diagnosis
  • Ascites* / etiology
  • Ascites* / therapy
  • Clinical Deterioration
  • Fatal Outcome
  • Hepatic Encephalopathy / diagnosis
  • Hepatic Encephalopathy / etiology
  • Hepatic Encephalopathy / therapy
  • Humans
  • Image-Guided Biopsy / methods
  • Immunoglobulin lambda-Chains / isolation & purification
  • Intestinal Obstruction / diagnosis
  • Intestinal Obstruction / etiology
  • Intestinal Obstruction / therapy
  • Liver Failure, Acute* / diagnosis
  • Liver Failure, Acute* / etiology
  • Liver Failure, Acute* / therapy
  • Liver Function Tests / methods
  • Liver* / diagnostic imaging
  • Liver* / pathology
  • Male
  • Middle Aged
  • Paracentesis / methods
  • Plaque, Amyloid* / diagnostic imaging
  • Plaque, Amyloid* / metabolism
  • Plaque, Amyloid* / pathology

Substances

  • Immunoglobulin lambda-Chains